CircSEC24A (hsa_circ_0003528) interference suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells via miR-421/MMP3 axis

References

• European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012 Apr 01;56(4):908–943.
   PubMed Web of Science ®Google Scholar
• Degasperi E, Colombo M. Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease. Lancet Gastroenterol Hepatol. 2016 Oct 01;1(2):156–164.
   PubMed Web of Science ®Google Scholar
• Liang Q, Shen X, Precision Medicine: SG. Update on diagnosis and therapeutic strategies of hepatocellular carcinoma. CURR MED CHEM. 2018 Jan 20;25(17):1999–2008.
   PubMed Web of Science ®Google Scholar
• Forner A, Reig M, Bruix J. Hepatocellular carcinoma. LANCET. 2018 Mar 31;391(10127):1301–1314.
   PubMed Web of Science ®Google Scholar
• Jiang H, Cao HJ, Ma N, et al. Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis. Proc Natl Acad Sci U S A. 2020 Mar 03;117(9):4770–4780.
   PubMed Web of Science ®Google Scholar
• Yang LY, Luo Q, Lu L, et al. Increased neutrophil extracellular traps promote metastasis potential of hepatocellular carcinoma via provoking tumorous inflammatory response. J HEMATOL ONCOL. 2020 Jan 06;13(1):3.
   PubMed Web of Science ®Google Scholar
• Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. TRENDS CELL BIOL. 2019 Mar 01;29(3):212–226.
   PubMed Web of Science ®Google Scholar
• Suarez-Carmona M, Lesage J, Cataldo D, et al. EMT and inflammation: inseparable actors of cancer progression. MOL ONCOL. 2017 Jul 01;11(7):805–823.
   PubMed Web of Science ®Google Scholar
• Paolillo M, Schinelli S. Extracellular matrix alterations in metastatic processes. INT J MOL SCI. 2019 Oct 07;20(19):4947.
   PubMed Web of Science ®Google Scholar
• Serrano-Gomez SJ, Maziveyi M, Alahari SK. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. MOL CANCER. 2016 Feb 24;15:18.
   PubMed Web of Science ®Google Scholar
• Giannelli G, Koudelkova P, Dituri F, et al. Role of epithelial to mesenchymal transition in hepatocellular carcinoma. J HEPATOL. 2016 Oct 01;65(4):798–808.
   PubMed Web of Science ®Google Scholar
• Dong Y, Zheng Q, Wang Z, et al. Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis. J HEMATOL ONCOL. 2019 Nov 08;12(1):112.
   PubMed Web of Science ®Google Scholar
• Patop IL, Wust S, Kadener S. Past, present, and future of circRNAs. EMBO J. 2019 Aug 15;38(16):e100836.
   PubMed Web of Science ®Google Scholar
• Yu T, Wang Y, Fan Y, et al. CircRNAs in cancer metabolism: a review. J HEMATOL ONCOL. 2019 Sep 04;12(1):90.
   PubMed Web of Science ®Google Scholar
• Liu Z, Yu Y, Huang Z, et al. CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression. CELL DEATH DIS. 2019 Nov 27;10(12):900.
   PubMed Web of Science ®Google Scholar
• Cai Y, Circular JY. RNA SOX5 promotes the proliferation and inhibits the apoptosis of the hepatocellular carcinoma cells by targeting miR-502-5p/synoviolin 1 axis. BIOENGINEERED. 2022 Jan 01;13(2):3362–3370.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Tang W, Zhuo H, et al. Cancer-associated fibroblast exosomes promote chemoresistance to cisplatin in hepatocellular carcinoma through circZFR targeting signal transducers and activators of transcription (STAT3)/ nuclear factor -kappa B (NF-kappaB) pathway. BIOENGINEERED. 2022 Mar 01;13(3):4786–4797.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang S, Wang H, et al. Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway. MOL CANCER. 2019 Jan 01;18(1):20.
   PubMed Web of Science ®Google Scholar
• Nagy A, Lanczky A, Menyhart O, et al. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep. 2018 Jun 15;8(1):9227.
   PubMed Web of Science ®Google Scholar
• Conn SJ, Pillman KA, Toubia J, et al. The RNA binding protein quaking regulates formation of circ. RNAs. CELL. 2015 Mar 12;160(6):1125–1134.
   PubMed Web of Science ®Google Scholar
• Shang BQ, Li ML, Quan HY, et al. Functional roles of circular RNAs during epithelial-to-mesenchymal transition. MOL CANCER. 2019 Sep 16;18(1):138.
   PubMed Web of Science ®Google Scholar
• Lu X, Gan Q, Circular GC. RNA circSEC24A promotes cutaneous squamous cell carcinoma progression by regulating miR-1193/MAP3K9 axis. Onco Targets Ther. 2021 Jan 20;14:653–666.
   PubMed Web of Science ®Google Scholar
• Chen Y, Xu S, Liu X, et al. CircSEC24 aupregulates TGFBR2 expression to accelerate pancreatic cancer proliferation and migration via sponging to miR-606. CANCER CELL INT. 2021 Dec 14;21(1):671.
   PubMed Web of Science ®Google Scholar
• Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets--update. NUCLEIC ACIDS RES. 2013 Jan 01;41:D991–5.
   PubMed Web of Science ®Google Scholar
• Lv R, Pan X, Song L, et al. MicroRNA-200a-3p accelerates the progression of osteoporosis by targeting glutaminase to inhibit osteogenic differentiation of bone marrow mesenchymal stem cells. BIOMED PHARMACOTHER. 2019 Aug 01;116:108960.
   PubMed Web of Science ®Google Scholar
• Hatzis C, Sun H, Yao H, et al. Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancers. J Natl Cancer Inst. 2011 Dec 21;103(24):1871–1883.
   PubMedGoogle Scholar
• Zhang Y, Zhang Y, Wang S, et al. SP1-induced lncRNA ZFPM2 antisense RNA 1 (ZFPM2-AS1) aggravates glioma progression via the miR-515-5p/Superoxide dismutase 2 (SOD2) axis. BIOENGINEERED. 2021 Jan 01;12(1):2299–2310.
   PubMed Web of Science ®Google Scholar
• Omar Zaki SS, Kanesan L, Leong MYD, et al. The influence of serum‐supplemented culture media in a transwell migration assay. CELL BIOL INT. 2019 Jan 01;43(10):1201–1204.
   PubMed Web of Science ®Google Scholar
• Yin N, Zhu L, Ding L, et al. MiR-135-5p promotes osteoblast differentiation by targeting HIF1AN in MC3T3-E1 cells. CELL MOL BIOL LETT. 2019 Jan 20;24:51.
   PubMed Web of Science ®Google Scholar
• Cheng B, Rong A, Zhou Q, et al. LINC00662 promotes colon cancer tumor growth and metastasis by competitively binding with miR-340-5p to regulate CLDN8/IL22 co-expression and activating ERK signaling pathway. J Exp Clin Cancer Res. 2020 Jan 03;39(1):5.
   PubMed Web of Science ®Google Scholar
• Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding. RNAs. CELL. 2007 Jun 29;129(7):1311–1323.
   PubMed Web of Science ®Google Scholar
• Han TS, Hur K, Cho HS, et al. Epigenetic Associations between lncRNA/circRNA and miRNA in hepatocellular carcinoma. Cancers (Basel). 2020 Sep 14;12(9):2622.
   PubMed Web of Science ®Google Scholar
• Su Y, Lv X, Yin W, et al. CircRNA Cdr1as functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression. Aging (Albany NY). 2019 Oct 01;11(19):8183–8203.
   PubMedGoogle Scholar
• Yao Z, Xu R, Yuan L, et al. Circ_0001955 facilitates hepatocellular carcinoma (HCC) tumorigenesis by sponging miR-516a-5p to release TRAF6 and MAPK11. CELL DEATH DIS. 2019 Dec 10;10(12):945.
   PubMed Web of Science ®Google Scholar
• Li X, Ding J, Wang X, et al. NUDT21 regulates circRNA cyclization and ceRNA crosstalk in hepatocellular carcinoma. ONCOGENE. 2020 Jan 01;39(4):891–904.
   PubMed Web of Science ®Google Scholar
• Liang X, Zhang L, Ji Q, et al. miR-421 promotes apoptosis and suppresses metastasis of osteosarcoma cells via targeting LTBP2. J CELL BIOCHEM. 2019 Mar 28;120:10978–10987.
   PubMed Web of Science ®Google Scholar
• Ye W, Ni Z, Yicheng S, et al. Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNAMeg3/miR421/PDGFRA axis. INT J ONCOL. 2019 Dec 01;55(6):1296–1312.
   PubMed Web of Science ®Google Scholar
• Liu L, Cui S, Zhang R, et al. MiR-421 inhibits the malignant phenotype in glioma by directly targeting MEF2D. AM J CANCER RES. 2017 Jan 20;7(4):857–868.
   PubMed Web of Science ®Google Scholar
• Shopit A, Li X, Tang Z, et al. miR-421 up-regulation by the oleanolic acid derivative K73-03 regulates epigenetically SPINK1 transcription in pancreatic cancer cells leading to metabolic changes and enhanced apoptosis. PHARMACOL RES. 2020 Nov 01;161:105130.
   PubMed Web of Science ®Google Scholar
• Ren F, Shrestha C, Shi H, et al. Targeting of KDM5A by miR-421 in human ovarian cancer suppresses the progression of ovarian cancer cells. Onco Targets Ther. 2020 Jan 20;13:9419–9428.
   PubMed Web of Science ®Google Scholar
• Wang W, Li Y, Li X, et al. Circular RNA circ-FOXP1 induced by SOX9 promotes hepatocellular carcinoma progression via sponging miR-875-3p and miR-421. BIOMED PHARMACOTHER. 2020 Jan 01;121:109517.
   PubMed Web of Science ®Google Scholar
• Xu L, Feng X, Hao X, et al. CircSETD3 (hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth. J Exp Clin Cancer Res. 2019 Feb 22;38(1):98.
   PubMed Web of Science ®Google Scholar
• Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. CELL. 2010 Apr 02;141(1):52–67.
   PubMed Web of Science ®Google Scholar
• Winer A, Adams S, Mignatti P. Matrix metalloproteinase inhibitors in cancer therapy: turning past failures into future successes. MOL CANCER THER. 2018 Jun 01;17(6):1147–1155.
   PubMed Web of Science ®Google Scholar
• Jin Y, Li Y, Wang X, et al. Dysregulation of MiR-519d affects oral squamous cell carcinoma invasion and metastasis by targeting MMP3. J CANCER. 2019 Jan 20;10(12):2720–2734.
   PubMed Web of Science ®Google Scholar
• Chen CL, Zhang L, Jiao YR, et al. miR-134 inhibits osteosarcoma cell invasion and metastasis through targeting MMP1 and MMP3 in vitro and in vivo. FEBS LETT. 2019 May 01;593(10):1089–1101.
   PubMed Web of Science ®Google Scholar
• Pittayapruek P, Meephansan J, Prapapan O, et al. Role of matrix metalloproteinases in photoaging and Photocarcinogenesis. INT J MOL SCI. 2016 Jun 02;17(6):868.
   PubMed Web of Science ®Google Scholar
• Wang W, Lin H, Zhou L, et al. MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma. Eur J Surg Oncol. 2014 Nov 01;40(11):1586–1594.
   PubMed Web of Science ®Google Scholar
• Lin YH, Liao CJ, Huang YH, et al. Thyroid hormone receptor represses miR-17 expression to enhance tumor metastasis in human hepatoma cells. ONCOGENE. 2013 Sep 19;32(38):4509–4518.
   PubMed Web of Science ®Google Scholar
• Przybylo JA, Radisky DC. Matrix metalloproteinase-induced epithelial-mesenchymal transition: tumor progression at Snail’s pace. Int J Biochem Cell Biol. 2007 Jan 20;39(6):1082–1088.
   PubMed Web of Science ®Google Scholar
• Zhang M, Dai C, Zhu H, et al. Cyclophilin A promotes human hepatocellular carcinoma cell metastasis via regulation of MMP3 and MMP9. MOL CELL BIOCHEM. 2011 Nov 01;357(1–2):387–395.
   PubMed Web of Science ®Google Scholar
• Scheau C, Badarau IA, Costache R, et al. The role of matrix metalloproteinases in the epithelial-mesenchymal transition of hepatocellular carcinoma. Anal Cell Pathol (Amst). 2019 Jan 20;2019:9423907.
   PubMedGoogle Scholar